Oracle Health Sciences to Provide Clinical E-Monitoring Solution to Bayer HealthCare
REDWOOD SHORES, CA – February 10, 2016 – Boosting clinical development productivity and efficiency is a top priority for life sciences organizations. To that end, Oracle today announced that two of its core Health Sciences offerings - Oracle Siebel Clinical Trial Management System and Oracle Health Sciences Clinical Development Analytics - have been selected by Bayer HealthCare, to oversee and manage the company’s clinical monitoring processes. Bayer HealthCare, a subgroup of Bayer AG researches, develops, manufactures, and markets pharmaceutical and medical products.
Oracle’s life sciences-specific solutions, combined with its broader product and service offering, are used by thousands of pharma, biopharma, and academic research centers worldwide to redesign clinical R&D processes, advance drug therapies, and optimize care delivery to improve the health, well-being, and lives of people globally.
“Oracle Health Sciences is committed to helping organizations, such as Bayer HealthCare, advance its vision of innovation to drive faster, safer, and more cost-effective therapies and treatments to improve lives around the globe,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “Our proven solutions are helping industry leaders, as well as emerging organizations, power innovation across the clinical development lifecycle.”
Oracle Siebel Clinical Trial Management System manages and monitors clinical testing sites for any issues as they arise. Oracle Health Sciences Clinical Development Analytics provides an effective platform that optimizes actionable, clinical analytics, addresses compliance issues, and monitors resources. Together, these solutions give clinical research associates greater visibility into site performance, with the ability to track open issues to resolution and manage risk.
Oracle Health Sciences’ advanced clinical trial solutions for data collection, management, and analysis help optimize research, mitigate risk, monitor/report adverse events, and drive medical insight for precision medicine
Additional Information
To learn more about Oracle Health Sciences, please follow @OracleHealthSci and Oracle Health Sciences.
About Oracle
Oracle offers a comprehensive and fully integrated stack of cloud applications and platform services. For more information about Oracle (NYSE:ORCL), visit oracle.com.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
